ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene.

Nathalie Majeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.